Edward Michael Collins, APN - Medicare Nurse Practitioner in Paterson, NJ

Edward Michael Collins, APN is a medicare enrolled "Nurse Practitioner - Acute Care" in Paterson, New Jersey. His current practice location is 703 Main St, Paterson, New Jersey. You can reach out to his office (for appointments etc.) via phone at (973) 754-2240.

Edward Michael Collins is licensed to practice in New Jersey (license number 26NJ00128900) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1144373705.

Contact Information

Edward Michael Collins, APN
703 Main St,
Paterson, NJ 07503-2621
(973) 754-2240
Not Available



Provider's Profile

Full NameEdward Michael Collins
GenderMale
SpecialityNurse Practitioner - Acute Care
Location703 Main St, Paterson, New Jersey
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1144373705
  • Provider Enumeration Date: 01/18/2007
  • Last Update Date: 10/01/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 0244330330
  • Enrollment ID: I20070702000371

Medical Identifiers

Medical identifiers for Edward Michael Collins such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144373705NPI-NPPES
0144843MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
163WE0003XRegistered Nurse - Emergency 26NO111105 (New Jersey)Secondary
363LA2100XNurse Practitioner - Acute Care 26NJ00128900 (New Jersey)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Edward Michael Collins allows following entities to bill medicare on his behalf.
Entity NameHackensack Meridian Health Medical Group - Specialty Care Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215989249
PECOS PAC ID: 9133032519
Enrollment ID: O20031111000524

News Archive

California's ACA rates to rise 8.7% next year

Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

FDA approves GSK's raxibacumab to treat inhalational anthrax

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

Memory Pharmaceuticals issued key U.S. patent for series of nicotinic alpha-7 receptor agonists

Memory Pharmaceuticals Corp. has announced the issuance of U.S. Patent No. 7,429,664, which provides composition of matter patent protection for a series of nicotinic alpha-7 receptor agonists.

Read more Medical News

› Verified 1 days ago

Entity NameSt Josephs Healthcare Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1497791297
PECOS PAC ID: 9739171984
Enrollment ID: O20040330001612

News Archive

California's ACA rates to rise 8.7% next year

Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

FDA approves GSK's raxibacumab to treat inhalational anthrax

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

Memory Pharmaceuticals issued key U.S. patent for series of nicotinic alpha-7 receptor agonists

Memory Pharmaceuticals Corp. has announced the issuance of U.S. Patent No. 7,429,664, which provides composition of matter patent protection for a series of nicotinic alpha-7 receptor agonists.

Read more Medical News

› Verified 1 days ago

Entity NameFaster Urgent Care, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1326291253
PECOS PAC ID: 8123177896
Enrollment ID: O20090529000100

News Archive

California's ACA rates to rise 8.7% next year

Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

FDA approves GSK's raxibacumab to treat inhalational anthrax

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

Memory Pharmaceuticals issued key U.S. patent for series of nicotinic alpha-7 receptor agonists

Memory Pharmaceuticals Corp. has announced the issuance of U.S. Patent No. 7,429,664, which provides composition of matter patent protection for a series of nicotinic alpha-7 receptor agonists.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Edward Michael Collins is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Edward Michael Collins, APN
24 Shadyside Rd,
Hewitt, NJ 07421-2311

Ph: (201) 406-8786
Edward Michael Collins, APN
703 Main St,
Paterson, NJ 07503-2621

Ph: (973) 754-2240

News Archive

California's ACA rates to rise 8.7% next year

Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

FDA approves GSK's raxibacumab to treat inhalational anthrax

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

Memory Pharmaceuticals issued key U.S. patent for series of nicotinic alpha-7 receptor agonists

Memory Pharmaceuticals Corp. has announced the issuance of U.S. Patent No. 7,429,664, which provides composition of matter patent protection for a series of nicotinic alpha-7 receptor agonists.

Read more News

› Verified 1 days ago


Nurse Practitioner Nurses in Paterson, NJ

Susan Mugalu, ANP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 703 Main St, Paterson, NJ 07503
Phone: 973-754-0000    
Diane E Mcclure, CPNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 703 Main St, Paterson, NJ 07503
Phone: 973-754-2555    Fax: 973-754-2567
Cynthia Dayrit -demetillo, NP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 1040 Main St, Paterson, NJ 07503
Phone: 973-782-6615    Fax: 973-782-6618
Mrs. Kathleen Ann Connolly,
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 393 Main St, Paterson, NJ 07501
Phone: 973-523-6220    Fax: 973-825-7201
Mr. Michael Pasquale, MSN, RN, APN-C
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 703 Main St, Paterson, NJ 07503
Phone: 973-754-3857    
Nidia Ortega, APN
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 416 Park Ave, Paterson, NJ 07504
Phone: 973-684-8138    Fax: 973-684-0032
Kassidy Katona, APN
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 680 Broadway Ste 104, Paterson, NJ 07514
Phone: 973-239-9400    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.